Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferroglycine sulfate absorption in patients with heart failure and iron deficiency
2017-000158-21Phase 4Completed
- Sponsor
- Karolinska Institutet
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ferroglycine sulfate in chronic heart failure (CHF) and iron deficiency anemia (IDA) (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Iron concentration in plasma. Started Feb 2017; status: completed.
02
Drugs
ferroglycine sulfate
03
Conditions
chronic heart failure (CHF)iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2017-000158-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000158-21.